Cargando…
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Fibrotic diseases encompass a wide spectrum of clinical entities including systemic fibrotic diseases such as systemic sclerosis, sclerodermatous graft versus host disease, nephrogenic systemic fibrosis, and IgG(4)-associated sclerosing disease, as well as numerous organ-specific disorders including...
Autores principales: | Piera-Velazquez, Sonsoles, Mendoza, Fabian A., Jimenez, Sergio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850468/ https://www.ncbi.nlm.nih.gov/pubmed/27077889 http://dx.doi.org/10.3390/jcm5040045 |
Ejemplares similares
-
Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases
por: Piera-Velazquez, Sonsoles, et al.
Publicado: (2012) -
Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance
por: Platel, Valentin, et al.
Publicado: (2019) -
Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI
por: Patschan, Daniel, et al.
Publicado: (2015) -
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study
por: Corallo, Claudio, et al.
Publicado: (2016) -
Vascular endothelial primary cilia regulate blood flow-induced EndoMT
por: Hierck, B, et al.
Publicado: (2012)